PegBio Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2020	FY 2019	FY 2018
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Operating Revenue	-	-	-	-	0	0
Other Revenue	-	-	-	-	0.24	0.11
Revenue	-	-	-	-	0.24	0.11
Revenue Growth (YoY)	-	-	-	-	122.72%	-
Cost of Revenue	-	-	-	4.76	0.22	0.05
Gross Profit	-	-	-	-4.76	0.02	0.06
Selling, General & Admin	164.11	192.43	55.36	32.32	66.39	8.64
Research & Development	57.68	95.43	236.73	95.42	151.03	87.69
Other Operating Expenses	-0.07	-0.27	-2.81	0.26	0.02	0.01
Operating Expenses	221.72	287.59	289.28	128.08	217.47	96.35
Operating Income	-221.72	-287.59	-289.28	-132.85	-217.45	-96.29
Interest Expense	-2.88	-2.5	-1.73	-3.15	-1.51	-0.39
Interest & Investment Income	0.34	0.8	5.29	1	1.03	1.03
Currency Exchange Gain (Loss)	-1.53	-	-	-0.42	0.12	1.55
Other Non Operating Income (Expenses)	0	-0.08	0.22	-0.18	-0.01	-0.01
EBT Excluding Unusual Items	-225.79	-289.36	-285.51	-135.59	-217.83	-94.11
Gain (Loss) on Sale of Investments	4.26	6.01	6.33	-	-	-
Other Unusual Items	-	-	-	3.67	8.23	1.13
Pretax Income	-221.53	-283.35	-279.18	-131.92	-209.6	-92.98
Earnings From Continuing Operations	-221.53	-283.35	-279.18	-131.92	-209.6	-92.98
Minority Interest in Earnings	0.12	0.19	0.18	1.57	2.81	1.59
Net Income	-221.41	-283.16	-279	-130.35	-206.79	-91.39
Net Income to Common	-221.41	-283.16	-279	-130.35	-206.79	-91.39
Shares Outstanding (Basic)	370	367	362	266	-	-
Shares Outstanding (Diluted)	370	367	362	266	-	-
Shares Change (YoY)	0.12%	1.40%	35.93%	-	-	-
EPS (Basic)	-0.60	-0.77	-0.77	-0.49	-	-
EPS (Diluted)	-0.60	-0.77	-0.77	-0.49	-	-
Free Cash Flow	-	-184.32	-233.9	-189.12	-69.04	-69.49
Free Cash Flow Per Share	-	-0.50	-0.65	-0.71	-	-
Gross Margin	-	-	-	-	9.71%	58.47%
Operating Margin	-	-	-	-	-89706.26%	-88469.31%
Profit Margin	-	-	-	-	-85309.15%	-83965.69%
Free Cash Flow Margin	-	-	-	-	-28482.33%	-63842.09%
EBITDA	-221.13	-286.76	-287.99	-131.91	-216.38	-95.69
D&A For EBITDA	0.6	0.83	1.3	0.93	1.07	0.6
EBIT	-221.72	-287.59	-289.28	-132.85	-217.45	-96.29

Source: S&P Global Market Intelligence. Standard template. Financial Sources.